Metric Finance
LearnFAQ
LearnFAQ

Learn / AGIO

NASDAQ: AGIO

Agios Pharmaceuticals (AGIO) stock, explained like you're 5

Agios Pharmaceuticals trades on the Nasdaq under the ticker AGIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.

Ticker
AGIO
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.9 billion dollars

Is Agios Pharmaceuticals a small, medium or large cap company?

No. Agios Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.9 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Agios Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves AGIO stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Agios Pharmaceuticals, Inc. (AGIO) stock price, news, quote and history (Yahoo Finance UK)
  • How Investors May Respond To Agios Pharmaceuticals (AGIO) Sickle Cell FDA Review (Simply Wall Street)
  • Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA Related) (The Motley Fool)
  • (AGIO) and the Role of Price Sensitive Allocations (Stock Traders Daily)
  • AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know (Yahoo Finance)

Follow AGIO in your daily brief

Each trading day at 5 PM ET we post what happened to Agios Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow AGIO

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Agios Pharmaceuticals stock

What does Agios Pharmaceuticals do?

Agios Pharmaceuticals trades on the Nasdaq under the ticker AGIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.

What is the ticker symbol for Agios Pharmaceuticals?

Agios Pharmaceuticals trades under the ticker AGIO on the Nasdaq.

What is Agios Pharmaceuticals's market cap?

Agios Pharmaceuticals is a small cap stock with a market cap of about 1.9 billion dollars.

How does Agios Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves AGIO stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow AGIO stock every day?

Add AGIO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow AGIO daily

A free brief on Agios Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare AGIO: AGIO vs NVS, AGIO vs AZN, AGIO vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed